Prognostic value of the neutrophil-to-lymphocyte ratio in the ARQ 197-215 second-line study for advanced hepatocellular carcinoma

The ARQ 197-215 study randomized patients to tivantinib or placebo and pre-specified efficacy analyses indicated the predictive value of MET expression as a marker of benefit from tivantinib in hepatocellular carcinoma (HCC). We aimed to explore the neutrophil-to-lymphocyte ratio (NLR) in 98 ARQ 197...

Descripción completa

Detalles Bibliográficos
Autores principales: Personeni, Nicola, Giordano, Laura, Abbadessa, Giovanni, Porta, Camillo, Borbath, Ivan, Daniele, Bruno, Laethem, Jean-Luc Van, Vlierberghe, Hans Van, Trojan, Jörg, De Toni, Enrico N., Gasbarrini, Antonio, Lencioni, Monica, Lamar, Maria E., Wang, Yunxia, Shuster, Dale, Schwartz, Brian, Santoro, Armando, Rimassa, Lorenza
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5362414/
https://www.ncbi.nlm.nih.gov/pubmed/28122337
http://dx.doi.org/10.18632/oncotarget.14797

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5362414/
https://www.ncbi.nlm.nih.gov/pubmed/28122337
http://dx.doi.org/10.18632/oncotarget.14797

Ejemplares similares